secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2026-09-30T11:15:20+00:00
Accession:  0001193125-26-408289
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Moderna names Juan Andres as first COO effective Oct 5; Jerh Collins to retire
------------------------------------------------------------------------------

- Juan Andres returns to Moderna as Chief Operating Officer, effective October 5, 2026, reporting to CEO Stephane Bancel and serving on the Executive Committee.
- Andres' pay: $800,000 base salary, 90% annual bonus target, $5,000,000 new-hire equity award vesting over four years (max 75% in RSUs).
- Future annual equity award target set at $4,000,000-$5,000,000, subject to Compensation Committee approval.
- Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer since January 2023, is retiring; he joined Moderna in October 2022 after nearly 30 years at Novartis.
- Company cites preparation for potential launch of intismeran autogene after positive Phase 3 results; the therapy is co-developed with Merck (MSD).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000119312526408289/0001193125-26-408289-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000119312526408289/d18337d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-408289

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer